|
|
Astralis, Ltd. does not have significant operations. Previously, it was engaged in the research and development of treatments for immune system disorders and skin diseases, such as psoriasis, and psoriatic and rheumatoid arthritis. The company was founded in 1999 and is based in Fairfield, New Jersey.
Web Address |
|
Phone |
973-227-7168 |
FAX |
(973) 227-7169 |
Contact |
SkyePharma PLC BO |
See Also: Historical Stats
See Also: Drug Manufacturers - Other Page
Other Company Info: Goldmood Company Index
Other Company Info: Main Menu
|
||||||
| Yahoo | Quote | Fool | MSN | Nasdaq | OTC | Reuters |
| ClearStation | MarketWatch | Stockhouse | Edgar | TSX | SEC | |
For the nine months ended 30 September 2006, Astralis, Ltd. reported no revenue. Net loss applicable to Common decreased 58% to $1.3M. Revenues reflect the Company being in the development stage. Lower loss reflects a decrease in research & development expense due to the completion of the Psoraxine (R) clinical trial & management cost, lower selling & administration expenses, decreased depreciation & amortization expenses.
